Zolgensma, Novartis' gene therapy drug for spinal muscular atrophy, recently demonstrated significant therapeutic benefits for patients in various extended clinical trials, reports Pharmaceutical Technology.
The Latest
Two chief residents in the orthopedic department of Rochester, Minn.-based Mayo Clinic paid tribute to John Lennon with a rendition of his song 'Imagine' on March 24, reports ABC News.
The North American Spine Society issued a call for papers for its new online journal, NASSJ.
Closures and service disruptions related to the COVID-19 outbreak are causing financial hardship across the healthcare industry, affecting anesthesia groups, spine and orthopedic practices, device companies, and surgery centers.
Medtronic's charitable arm is pledging an additional $10 million toward COVID-19 relief efforts, the device company announced March 25.
Becker's Spine Review has reported on 16 confirmed cases of COVID-19 affecting spine and orthopedic groups, physicians, or specialty-leading hospitals since mid-March:
The board of managers at Bioventus unanimously appointed Ken Reali to succeed Tony Bihl as CEO when he retires April 20.
Precision Spine on March 25 launched its Reform Posterior Occipital Cervical Thoracic system.
Telemedicine services are rapidly increasing across the country after the Trump administration's March 13 declaration to expand Medicare coverage for the technology in the wake of the COVID-19 pandemic.
Here are seven orthopedic surgeons making the news this week: